title: Complete resolution of febrile ulceronecrotic Mucha-Habermann disease following infliximab therapy.
authors.affiliation: Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital, Oberhausen. Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Kreuter
authors.affiliation: Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital, Oberhausen. Germany.
authors.forename: Sarah
authors.initials: S
authors.lastname: Knispel
authors.affiliation: Institute for Virology, National Reference Center for Papilloma- und Polyomaviruses, University of Cologne, Cologne, Germany.
authors.forename: Ulrike
authors.initials: U
authors.lastname: Wieland
authors.affiliation: Pathological Institute Rhein-Ruhr, Mülheim an der Ruhr, Germany.
authors.forename: Frank
authors.initials: F
authors.lastname: Oellig
authors.affiliation: Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital, Oberhausen. Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Tigges
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D006561:Herpes Simplex / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage*; D008297:Male; D017514:Pityriasis Lichenoides / Q000188:drug therapy* / Q000473:pathology*; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000069285:Infliximab